The Current Ratio as of November 2024 (TTM) for Immix Biopharma, Inc. (IMMX) is 3.47

According to Immix Biopharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.47. This represents a change of -35.83% compared to the average of 5.40 of the last 4 quarters.

Immix Biopharma, Inc. (IMMX) Historical Current Ratio (quarterly & annually)

How has IMMX Current Ratio performed in the past?

The mean historical Current Ratio of Immix Biopharma, Inc. over the last ten years is 21.47. The current 3.47 Current Ratio has changed 1.51% with respect to the historical average. Over the past ten years (40 quarters), IMMX's Current Ratio was at its highest in in the December 2021 quarter at 90.01. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Immix Biopharma, Inc. (IMMX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Immix Biopharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immix Biopharma, Inc. (IMMX) Average Current Ratio

How has IMMX Current Ratio performed in the past?

The current Current Ratio of Immix Biopharma, Inc. (IMMX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Immix Biopharma, Inc. (IMMX) Current Ratio vs. Peers

How is IMMX’s Current Ratio compared to its peers?

Immix Biopharma, Inc.’s Current Ratio is greater than ZyVersa Therapeutics, Inc. (0.03), greater than Hepion Pharmaceuticals, Inc. (1.30), less than AVROBIO, Inc. (26.17), greater than eFFECTOR Therapeutics, Inc. (1.03), greater than CNS Pharmaceuticals, Inc. (1.82), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), less than Freeline Therapeutics Holdings plc (0), greater than Enveric Biosciences, Inc. (1.95), less than CohBar, Inc. (5.17), less than Elevation Oncology, Inc. (15.69), less than Ocean Biomedical, Inc. (17.77), greater than null (0.03),

Build a custom stock screener for Immix Biopharma, Inc. (IMMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immix Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immix Biopharma, Inc. (IMMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immix Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.